By EdU staining and CCK-8 assay, the results indicated that interference with LPCAT1 expression significantly inhibited the proliferative activity of HCC cells (all p < 0.05, Figures 10E–H). The gene discussed is LPCAT1; the disease is hepatocellular carcinoma.